Mr. Michael Gorenstein reports

CRONOS GROUP INC. ANNOUNCES RESULTS OF 2023 ANNUAL MEETING OF SHAREHOLDERS

At Cronos Group Inc.'s annual meeting of shareholders held yesterday, June 22, 2023, shareholders holding a total of 247,410,987 common shares of the company voted in person or by proxy, representing 64.96 per cent of the total number of common shares of the company outstanding.

Each of the directors listed as a nominee in the company's proxy statement dated April 28, 2023, was elected as a director of the company, with each director receiving in excess of 94.8 per cent of the votes cast in favour of his or her election. The detailed results of the vote for the election of directors are set out herein.

Shareholders also approved an advisory (non-binding) resolution on the compensation of the company's named executive officers, with 92.71 per cent of votes cast in favour of such resolution, and approved the reappointment of KPMG LLP as the company's independent auditor.

For complete results on all matters voted on at the meeting, please see the report of voting results filed on the company's SEDAR profile and the company's Form 8-K filed on EDGAR.

About Cronos Group Inc.

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos's diverse international brand portfolio includes Spinach, Peace Naturals and Lord Jones.

We seek Safe Harbor.